Response: Concerns with conclusions in the article by Sherwood 'Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice'.
作者信息
Sherwood James
机构信息
Innovative Medicines Biotech Unit, Precision Medicine and Genomics, Cambridge, UK.
出版信息
ESMO Open. 2018 Jan 3;3(1):e000294. doi: 10.1136/esmoopen-2017-000294. eCollection 2018.
Abstract
摘要
相似文献
1
Response: Concerns with conclusions in the article by Sherwood 'Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice'.回应：对舍伍德所著文章《13种KRAS突变检测技术的关键差异及其与临床实践的相关性》中的结论的担忧。
ESMO Open. 2018 Jan 3;3(1):e000294. doi: 10.1136/esmoopen-2017-000294. eCollection 2018.
2
Concerns with conclusions in the article by Sherwood 'Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice'.对舍伍德所著文章《13种KRAS突变检测技术的关键差异及其与临床实践的相关性》中的结论的担忧。
ESMO Open. 2018 Jan 3;3(1):e000287. doi: 10.1136/esmoopen-2017-000287. eCollection 2018.
3
Correction: .更正：.
ESMO Open. 2018 Jan 3;3(1):e000235corr1. doi: 10.1136/esmoopen-2017-000235corr1. eCollection 2018.
4
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.13种KRAS突变检测技术之间的关键差异及其与临床实践的相关性。
ESMO Open. 2017 Sep 28;2(4):e000235. doi: 10.1136/esmoopen-2017-000235. eCollection 2017.
5
Hybridization-Induced Aggregation Technology for Practical Clinical Testing: KRAS Mutation Detection in Lung and Colorectal Tumors.用于实际临床检测的杂交诱导聚集技术：肺癌和结直肠癌中KRAS突变检测
J Mol Diagn. 2016 Jul;18(4):546-53. doi: 10.1016/j.jmoldx.2016.02.004. Epub 2016 Jun 8.
6
Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy.西妥昔单抗联合化疗治疗的转移性结直肠癌中KRAS突变检测的临床相关性
Br J Cancer. 2007 Apr 23;96(8):1166-9. doi: 10.1038/sj.bjc.6603685. Epub 2007 Mar 20.
7
Sensitive detection of KRAS mutations using enhanced-ice-COLD-PCR mutation enrichment and direct sequence identification.利用增强型 ice-COLD-PCR 突变富集和直接测序鉴定技术进行 KRAS 基因突变的灵敏检测。
Hum Mutat. 2013 Nov;34(11):1568-80. doi: 10.1002/humu.22427. Epub 2013 Sep 17.
8
Increased sensitivity of KRAS mutation detection by high-resolution melting analysis of COLD-PCR products.高分辨率熔解曲线分析 COLD-PCR 产物提高 KRAS 基因突变检测的灵敏度。
Hum Mutat. 2010 Dec;31(12):1366-73. doi: 10.1002/humu.21358. Epub 2010 Oct 26.
9
The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma.黏液性卵巢癌中 Her2 扩增和 Kras 突变的状态。
Hum Genomics. 2016 Dec 28;10(1):40. doi: 10.1186/s40246-016-0096-9.
10
The Functional Effects of Key Driver KRAS Mutations on Gene Expression in Lung Cancer.关键驱动基因KRAS突变对肺癌基因表达的功能影响
Front Genet. 2020 Feb 4;11:17. doi: 10.3389/fgene.2020.00017. eCollection 2020.
本文引用的文献
1
Concerns with conclusions in the article by Sherwood 'Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice'.对舍伍德所著文章《13种KRAS突变检测技术的关键差异及其与临床实践的相关性》中的结论的担忧。
ESMO Open. 2018 Jan 3;3(1):e000287. doi: 10.1136/esmoopen-2017-000287. eCollection 2018.
2
Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practice.13种KRAS突变检测技术之间的关键差异及其与临床实践的相关性。
ESMO Open. 2017 Sep 28;2(4):e000235. doi: 10.1136/esmoopen-2017-000235. eCollection 2017.
3
Current and Emerging Applications of Droplet Digital PCR in Oncology.液滴数字 PCR 在肿瘤学中的当前和新兴应用。
Mol Diagn Ther. 2017 Oct;21(5):493-510. doi: 10.1007/s40291-017-0278-8.
4
International Interlaboratory Digital PCR Study Demonstrating High Reproducibility for the Measurement of a Rare Sequence Variant.国际实验室间数字 PCR 研究证明了稀有序列变异测量的高度可重复性。
Anal Chem. 2017 Feb 7;89(3):1724-1733. doi: 10.1021/acs.analchem.6b03980. Epub 2017 Jan 18.
5
Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer.前瞻性验证快速血浆基因分型检测晚期肺癌中 EGFR 和 KRAS 突变。
JAMA Oncol. 2016 Aug 1;2(8):1014-22. doi: 10.1001/jamaoncol.2016.0173.
6
Efficient Genotyping of KRAS Mutant Non-Small Cell Lung Cancer Using a Multiplexed Droplet Digital PCR Approach.使用多重液滴数字PCR方法对KRAS突变型非小细胞肺癌进行高效基因分型
PLoS One. 2015 Sep 28;10(9):e0139074. doi: 10.1371/journal.pone.0139074. eCollection 2015.
7
Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA.利用游离血浆DNA的定量下一代基因分型对EGFR突变型肺癌的反应和耐药性进行无创检测。
Clin Cancer Res. 2014 Mar 15;20(6):1698-1705. doi: 10.1158/1078-0432.CCR-13-2482. Epub 2014 Jan 15.
Zotero 插件